相似文献
1
Changing Trends in Stomach Cancer Throughout the World.
Curr Gastroenterol Rep. 2017 Aug;19(8):36. doi: 10.1007/s11894-017-0575-8.
2
Asia-Pacific consensus guidelines on gastric cancer prevention.
J Gastroenterol Hepatol. 2008 Mar;23(3):351-65. doi: 10.1111/j.1440-1746.2008.05314.x.
3
Epidemiology of Helicobacter pylori infection and gastric cancer in Asia.
J Gastroenterol Hepatol. 2010 Mar;25(3):479-86. doi: 10.1111/j.1440-1746.2009.06188.x.
4
Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections.
Cancer Causes Control. 2009 Dec;20(10):2021-9. doi: 10.1007/s10552-009-9397-9.
5
Review article: Helicobacter pylori and gastric cancer--the clinicians'point of view.
Aliment Pharmacol Ther. 2000 Oct;14 Suppl 3:48-54. doi: 10.1046/j.1365-2036.2000.00100.x.
6
Changing epidemiology of Helicobacter pylori in Asia.
J Dig Dis. 2008 Nov;9(4):186-9. doi: 10.1111/j.1751-2980.2008.00344.x.
7
The enigma of Helicobacter pylori infection and gastric cancer.
Indian J Gastroenterol. 2010 Jun;29(3):95-100. doi: 10.1007/s12664-010-0024-1. Epub 2010 Jun 29.
8
Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model.
PLoS Med. 2013;10(5):e1001451. doi: 10.1371/journal.pmed.1001451. Epub 2013 May 21.
9
Helicobacter pylori as a risk factor for cancer.
Baillieres Clin Gastroenterol. 1995 Sep;9(3):563-82. doi: 10.1016/0950-3528(95)90049-7.
10
Epidemiology of gastric cancer and perspectives for prevention.
Salud Publica Mex. 1997 Jul-Aug;39(4):318-30. doi: 10.1590/s0036-36341997000400010.
引用本文的文献
1
Epidemiological trends of early-onset gastrointestinal cancers from 1990 to 2021 and predictions for 2036: analysis from the global burden of disease study 2021.
Ann Med. 2025 Dec;57(1):2555518. doi: 10.1080/07853890.2025.2555518. Epub 2025 Sep 5.
2
Trends and Disparities in Mortality Due to Gastric Malignancies the United States: A Nationwide Analysis from 1999 to 2020.
J Gastrointest Cancer. 2025 Aug 5;56(1):168. doi: 10.1007/s12029-025-01295-9.
3
Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker- and Proton Pump Inhibitor-Based Bismuth Quadruple Therapy for Eradication: A Network Meta-Analysis.
Gastro Hep Adv. 2025 May 16;4(9):100705. doi: 10.1016/j.gastha.2025.100705. eCollection 2025.
4
Diagnostic accuracy of 18F-FDG and 68 Ga-FAPi PET/CT for patients with gastric carcinoma: a systematic review and meta-analysis.
Ann Nucl Med. 2025 Jul 11. doi: 10.1007/s12149-025-02082-z.
5
Impact of Pre-treatment Proteinuria Progression on the Risk of Increased Proteinuria During Ramucirumab Therapy.
Cancer Diagn Progn. 2025 Jun 30;5(4):437-452. doi: 10.21873/cdp.10457. eCollection 2025 Jul-Aug.
6
Trends in incidence and mortality of early-onset gastrointestinal cancers: a comprehensive study.
BMC Gastroenterol. 2025 Jun 2;25(1):424. doi: 10.1186/s12876-025-04015-6.
7
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study.
ESMO Open. 2025 May;10(5):105096. doi: 10.1016/j.esmoop.2025.105096. Epub 2025 May 12.
8
Causal link between mental disorders and gastrointestinal diseases: a Mendelian randomization study.
Front Endocrinol (Lausanne). 2025 Apr 22;16:1288619. doi: 10.3389/fendo.2025.1288619. eCollection 2025.
9
Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated with Neoadjuvant FLOT Regimen?
Cancer Control. 2025 Jan-Dec;32:10732748251335367. doi: 10.1177/10732748251335367. Epub 2025 Apr 18.
10
Long-Term Exposure to Nitrate and Trihalomethanes in Drinking Water and Gastric Cancer: A Multicase-Control Study in Spain (MCC-Spain).
Environ Health Perspect. 2025 May;133(5):57014. doi: 10.1289/EHP15039. Epub 2025 May 22.
本文引用的文献
1
Helicobacter pylori as an oncogenic pathogen, revisited.
Expert Rev Mol Med. 2017 Mar 21;19:e4. doi: 10.1017/erm.2017.4.
2
Racial and Ethnic Minorities at Increased Risk for Gastric Cancer in a Regional US Population Study.
Clin Gastroenterol Hepatol. 2017 Apr;15(4):511-517. doi: 10.1016/j.cgh.2016.11.033. Epub 2016 Dec 9.
3
Changing epidemiology of Helicobacter pylori in Japan.
Gastric Cancer. 2017 Mar;20(Suppl 1):3-7. doi: 10.1007/s10120-016-0658-5. Epub 2016 Oct 18.
4
Current Perspectives on Gastric Cancer.
Gastroenterol Clin North Am. 2016 Sep;45(3):413-28. doi: 10.1016/j.gtc.2016.04.002.
5
An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence.
Bull World Health Organ. 2016 Mar 1;94(3):174-84. doi: 10.2471/BLT.15.164384. Epub 2016 Jan 28.
6
Screening and surveillance for gastric cancer in the United States: Is it needed?
Gastrointest Endosc. 2016 Jul;84(1):18-28. doi: 10.1016/j.gie.2016.02.028. Epub 2016 Mar 3.
7
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
8
Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations.
Gut Liver. 2016 Jan;10(1):12-26. doi: 10.5009/gnl15091.
9
Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication.
Gastroenterol Clin North Am. 2015 Sep;44(3):609-24. doi: 10.1016/j.gtc.2015.05.009. Epub 2015 Jul 7.
10
Kyoto global consensus report on Helicobacter pylori gastritis.
Gut. 2015 Sep;64(9):1353-67. doi: 10.1136/gutjnl-2015-309252. Epub 2015 Jul 17.
Zotero 插件